Vertical: CNMBase Year: 2025
Market Size (2025)
$215.25M
Projected (2032)
$295.12M
CAGR (2022–2032)
4.6%
Key Players
10+
Market Overview
The Global Aquaculture Chemicals Market was valued at USD 215.25 Million in 2025 and is projected to reach USD 295.12 Million by 2032, registering a CAGR of 4.61% during 2026–2032. The market increased from USD 187.96 Million in 2022 to USD 205.74 Million in 2024, and is expected to add USD 79.88 Million in absolute value between 2025 and 2032.
Aquaculture chemicals comprise the disinfectants, water quality conditioners, probiotics and other specialty inputs used by hatcheries, nurseries and grow-out farms to maintain water quality, enforce biosecurity and manage stock health. Demand is linked directly to the volume and intensity of farmed aquatic animal production. According to the Food and Agriculture Organization of the United Nations (FAO), aquaculture produced 94.4 million tonnes of aquatic animals in 2022, exceeding capture fisheries (92.3 million tonnes) for the first time and accounting for 51% of aquatic animal production. Higher stocking densities, recurrent disease outbreaks in shrimp and finfish, and regulatory pressure to reduce antibiotic use are moving farmers towards preventive water treatment and biological products, which supports steady growth in chemical and biological input consumption per tonne of output.
Key Findings
By Product Type: Probiotics & Others is the largest segment, accounting for 40.0% of the market in 2025 (USD 86.10 Million). It is also the fastest-growing segment, with a CAGR of 5.70% during 2026–2032.
By Species: Shrimp and Fish each account for 45.0% of the market in 2025 (USD 96.86 Million each). Shrimp is the fastest-growing species segment, with a CAGR of 5.13%.
By Region: Asia Pacific is the leading region, with 80.0% of the market in 2025 (USD 172.20 Million). Middle East & Africa is the fastest-growing region, with a CAGR of 6.18%.
By Country: China is the leading country market, valued at USD 86.10 Million in 2025 (40.0% of the global market). Saudi Arabia is the fastest-growing country, with a CAGR of 8.30% during 2026–2032.
Segmentation Summary
By product type, Probiotics & Others held USD 86.10 Million in 2025, while Disinfectants and Water Quality Conditioners each accounted for USD 64.57 Million (30.0% each). Water Quality Conditioners are forecast to grow at a CAGR of 4.30%, ahead of Disinfectants at 3.36%, as farms place greater emphasis on continuous pond and tank management rather than episodic sanitation. The shift towards microbial products and other specialty inputs is reflected in the 5.70% CAGR of Probiotics & Others, which is expected to contribute USD 40.97 Million of the market's USD 79.88 Million absolute growth between 2025 and 2032.
By species, Shrimp and Fish are of equal size in 2025, but Shrimp is projected to reach USD 137.52 Million by 2032 against USD 129.90 Million for Fish, reflecting the intensive pond-based nature of shrimp farming and its high exposure to bacterial and viral disease. The Others segment, which covers molluscs and other farmed species, accounted for USD 21.52 Million in 2025 and is forecast to grow at a CAGR of 3.67%.
Regionally, Asia Pacific dominates consumption with USD 172.20 Million in 2025, supported by China (USD 86.10 Million) and India (USD 29.27 Million). India is forecast to grow at a CAGR of 6.20%, the highest among the major country markets in the region. Latin America (CAGR 5.24%) and Middle East & Africa (CAGR 6.18%) are smaller but faster-growing markets, driven by shrimp expansion in Latin America and new aquaculture investment in the Gulf states.
Competitive Landscape Summary
The market is fragmented. Multinational animal health, specialty chemical and biosolutions companies, such as Merck Animal Health, LANXESS, dsm-firmenich, Novonesis, Benchmark Holdings (INVE Aquaculture), Virbac, Solvay and Lallemand Animal Nutrition, compete alongside specialist fish health suppliers such as Syndel and a large number of regional formulators in China, India and Southeast Asia. Multinationals lead in regulated product categories such as approved fish medicines, branded disinfectants and registered probiotic strains, while local companies compete on price and distribution reach in pond-based shrimp and freshwater fish farming. Recent activity has centred on portfolio restructuring, including Merck Animal Health's acquisition of Elanco's aqua business (completed July 2024), the formation of Novonesis (January 2024), Benchmark Holdings' sale of its genetics business (completed March 2025), and dsm-firmenich's agreement to divest its Animal Nutrition & Health business (February 2026).
Challenges and Opportunities
The principal challenges are the cost and duration of regulatory approval for fish medicines and biocidal products, environmental concerns over chemical discharge from farms, price sensitivity among small-scale farmers, and the presence of unregistered or substandard products in several Asian markets. Resistance of parasites such as sea lice to repeated chemical treatments also limits the long-term effectiveness of some bath treatments.
Opportunities are concentrated in next-generation probiotics and bioremediation products, water treatment for recirculating aquaculture systems (RAS) and land-based farms, and emerging aquaculture markets in the Middle East, Africa and Latin America. Producers that combine registered products with on-farm technical service and water quality diagnostics are positioned to benefit from the transition to preventive health management.
Future Outlook
Through 2032, growth is expected to remain steady at a CAGR of 4.61%, with the market increasing from USD 225.19 Million in 2026 to USD 295.12 Million in 2032. The product mix is expected to continue shifting towards Probiotics & Others, whose share is projected to rise as farms reduce reliance on antibiotics and broad-spectrum chemicals. Asia Pacific will remain the centre of demand, while the fastest growth rates will be recorded in the Middle East & Africa and Latin America. Regulatory scrutiny of residues and discharges is expected to favour suppliers with registered, documented products.
The Aquaculture Chemicals Market market is projected to grow at a CAGR of 4.6% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Aquaculture chemicals are chemical and biological inputs applied to culture water, pond bottoms, tanks, equipment and farmed stock to maintain water quality, prevent the introduction and spread of pathogens, and support the health and productivity of farmed aquatic animals. They are used across the production cycle, from broodstock and hatchery operations to nursery and grow-out systems, including earthen ponds, raceways, net pens, cages and recirculating aquaculture systems (RAS).
For the purpose of this study, the market includes the following product categories:
Disinfectants: products used to sanitise ponds, tanks, equipment, vehicles, footbaths and eggs, and to treat culture water. These include oxidising agents (peroxygen compounds such as potassium peroxymonosulfate and hydrogen peroxide), halogen-based products (calcium hypochlorite, chloramine-T and povidone-iodine), quaternary ammonium compounds, formalin and glutaraldehyde.
Water Quality Conditioners: products used to correct and stabilise water and soil parameters. These include liming materials and alkalinity buffers, oxygen-releasing compounds, ammonia and hydrogen sulphide binders such as zeolites, flocculants and clarifiers, dechlorinating agents such as sodium thiosulfate, and mineral supplements for culture water.
Probiotics & Others: live microbial products applied to water, soil or feed (such as Bacillus-based, nitrifying and photosynthetic bacterial formulations), enzyme-based bioremediation products, and other specialty aquaculture chemicals, including anaesthetics and sedatives, and bath treatments used against external parasites.
The study excludes compound aquafeed and general feed ingredients, vaccines and other biologics, antibiotics administered as medicated feed, aquaculture equipment such as aerators, filters and ozone or UV systems, and chemicals used in seafood processing after harvest. Market values represent revenue generated from the sale of aquaculture chemicals at manufacturer level.
Scope of the Study
The study covers the Global Aquaculture Chemicals Market across three segmentations taken from the market estimation data: product type, species and region. Regional analysis is supported by country-level estimates for each region.
Research Objectives
To estimate the size of the global aquaculture chemicals market for the historic period 2022–2024 and the base year 2025, and to forecast its value for 2026–2032 in USD Million.
To analyse the market by product type (Disinfectants, Water Quality Conditioners, and Probiotics & Others) and identify the factors behind each segment's share and growth.
To assess demand by species (Shrimp, Fish and Others) with reference to farming systems, disease pressures and treatment practices.
To evaluate regional and country-level markets, with attention to major producing countries such as China, India and the shrimp- and salmon-producing countries of Latin America and Europe.
To identify the drivers, restraints, opportunities and trends that shape demand for aquaculture chemicals, including antibiotic reduction policies and biosecurity requirements.
To review the regulatory framework that governs the approval, registration and use of aquaculture disinfectants, fish medicines and probiotics in major regions.
To profile the competitive environment, including the positioning of leading suppliers and key developments from 2022 onward.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research, market size estimation and forecasting. The process began with defining the market and its segmentation, followed by the collection of production, trade and regulatory data for the aquaculture sector. Supplier revenues, product portfolios and channel structures were then reviewed to build a picture of the supply side. These inputs were validated through discussions with industry participants and consolidated into a market model, which was cross-checked using top-down and bottom-up approaches before the final estimates and forecasts were prepared.
Stage 1: Market definition, scope and segmentation framework
Stage 2: Secondary research on aquaculture production, disease incidence, regulation and supplier activity
Secondary Research
Secondary research was used to establish the production base, the regulatory environment and the supplier landscape. The main source types were:
Intergovernmental and government bodies: FAO fisheries and aquaculture statistics and the State of World Fisheries and Aquaculture (SOFIA) reports; national fisheries ministries and agencies such as NOAA Fisheries, the Department of Fisheries of India, the Ministry of Agriculture and Rural Affairs of China and Sernapesca in Chile.
Regulatory agencies: the U.S. Food and Drug Administration (approved aquaculture drugs), the U.S. Environmental Protection Agency, the European Medicines Agency, the European Chemicals Agency (biocidal products), and national medicines agencies such as the Norwegian Medical Products Agency.
Trade and export bodies: the Marine Products Export Development Authority (MPEDA) of India and national aquaculture chambers for shrimp export data.
Industry associations and research institutions: aquaculture associations, the Network of Aquaculture Centres in Asia-Pacific (NACA), the World Organisation for Animal Health (WOAH) for aquatic disease information, and peer-reviewed research on disease losses and treatment practices.
Company sources: annual reports, financial results, investor presentations, product registrations and press releases of chemical, animal health and biosolutions companies.
Trade journals and databases: aquaculture and seafood trade publications, and paid company and trade databases.
Primary Research
Primary research was conducted to validate secondary findings, obtain insight into pricing and usage practices, and test the assumptions used in the market model. Interviews were conducted on both the supply side and the demand side of the market.
Supply side: product managers, technical service managers and regional sales heads at aquaculture chemical, animal health and probiotic manufacturers; distributors and aqua dealers; and regulatory affairs specialists.
Demand side: hatchery and farm managers in shrimp and finfish operations, technical staff at integrated aquaculture companies, fish health veterinarians, and aquaculture researchers and extension specialists.
Objectives: to verify product usage patterns and dosing practices by species and system; to understand price levels and purchase channels; to assess the adoption of probiotics relative to conventional chemicals; and to obtain views on regulatory changes and growth prospects by region.
Market Size Estimation
Top-down approach: The market was estimated from total aquaculture production by species and country, adjusted for the share of production under semi-intensive and intensive culture, where chemical and biological inputs are used regularly. Average spending on aquaculture chemicals per tonne of output was applied to derive the value of the market, which was then split by product type using usage patterns obtained from primary research.
Bottom-up approach: The revenues of leading suppliers from aquaculture chemicals were estimated using company reports, product portfolios and regional presence, and were supplemented by estimates for regional and local formulators. These revenues were aggregated by product type and region to arrive at the market size.
Data triangulation: The results of the two approaches were compared and reconciled. Differences were examined against primary research inputs, and the final estimates were adjusted to ensure consistency across product type, species, region and country.
Forecasting Methodology
Forecasts for 2026–2032 were developed by projecting the demand base and the intensity of chemical use for each segment, region and country. The following factors were considered:
Projected aquaculture production growth by species and country
Trends in farm intensification, including the adoption of RAS and biofloc systems
Disease incidence and biosecurity practices in shrimp and finfish farming
Regulatory changes affecting the use of antibiotics, fish medicines and biocides
Adoption rates of probiotics and other biological alternatives
Price trends of key raw materials and finished products
Macroeconomic conditions and seafood trade flows
Each factor was assessed for its expected impact over the short, medium and long term, and the resulting growth rates were applied to the 2025 base year values to arrive at forecast values.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Market values are expressed in nominal USD at manufacturer level; currency fluctuations during the forecast period are not modelled separately.
Aquaculture production is assumed to grow without major disruption, such as a pandemic or a region-wide disease event outside historical norms.
Current regulatory frameworks are assumed to remain in force, with gradual tightening of antibiotic and residue controls in line with announced policies.
Sales of unregistered or informal products in some Asian, African and Latin American markets are difficult to measure and are estimated using primary research inputs.
Company-level information is limited for privately held suppliers, and segment-level revenues for aquaculture chemicals are rarely reported separately by diversified companies.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Aquaculture Chemicals Market is fragmented. No single supplier holds a dominant position across all product types and regions. Competition takes place at two levels. At the international level, animal health companies, specialty chemical producers and biosolutions companies compete with registered, branded products, technical service and regulatory expertise; these companies are strongest in regulated markets such as Europe, North America and Chile, and in premium segments such as approved fish medicines, branded disinfectants and authorised probiotic strains. At the local level, a large number of regional formulators and distributors in China, India, Southeast Asia and Latin America supply generic disinfectants, liming agents, mineral mixes and probiotic blends, competing mainly on price, dealer networks and farmer relationships.
Competitive strategies include portfolio expansion through acquisitions, registration of products in new countries, partnerships with feed companies and research institutions, and the development of biological alternatives to antibiotics and conventional chemicals. Since 2022, the competitive structure has been reshaped by several major transactions, including Merck Animal Health's acquisition of Elanco's aqua business, the creation of Novonesis, Benchmark Holdings' sale of its genetics business and subsequent delisting, and dsm-firmenich's agreement to divest its Animal Nutrition & Health business to CVC Capital Partners.
Key Player Positioning
Based on product portfolio breadth, geographic reach and position in aquaculture-specific product categories, the profiled companies are grouped as follows:
Leaders: Merck Animal Health, LANXESS, dsm-firmenich and Novonesis. These companies combine global distribution, strong brands and significant research capability. Merck Animal Health has the broadest aquaculture health portfolio following its acquisition of Elanco's aqua business; LANXESS's Virkon AQUATIC is a widely recognised aquaculture disinfectant brand; dsm-firmenich (AquaStar) and Novonesis (PondPlus, PondDtox) are major suppliers of pond and gut probiotics.
Challengers: Benchmark Holdings (INVE Aquaculture), Virbac, Solvay and Lallemand Animal Nutrition. These companies hold strong positions in specific species, product categories or regions, such as shrimp hatchery health products (INVE), salmon health in Chile (Virbac), hydrogen peroxide-based sea lice treatments (Solvay) and EU-authorised aquaculture probiotics (Lallemand).
Niche players: Syndel and Kemin Industries (Kemin AquaScience). Syndel has a broad range of FDA-approved fish health and water treatment products concentrated in North America, while Kemin focuses on functional health products for shrimp in Asia.
Competitor Dashboard
The competitor dashboard rates each profiled company on four parameters relevant to the aquaculture chemicals market: product portfolio, regional presence, strategic alliances and industry experience.
Threat of New Entrants – Medium
Entry barriers are low for generic pond chemicals and simple water conditioners, which local formulators can produce with limited capital.
Barriers are high for approved fish medicines, registered biocides and authorised probiotic strains because of the cost and time required for regulatory dossiers.
Established distributor relationships and technical service networks give incumbents an advantage in reaching farmers.
Bargaining Power of Suppliers – Medium
Key oxidisers such as hydrogen peroxide and halogen compounds are produced by a limited number of large chemical companies, which gives them pricing influence.
Many inputs are commodities with multiple sources, which limits supplier leverage for basic products.
Proprietary microbial strains and fermentation capacity are concentrated among specialist producers.
Bargaining Power of Buyers – High
Small and medium farms are price-sensitive and can switch easily between similar generic products.
Large integrated salmon and shrimp producers purchase in volume and negotiate prices and service terms.
Buyers have access to many local and international brands through dealer networks.
Threat of Substitutes – Medium
Vaccines, specific pathogen-free (SPF) broodstock and improved genetics reduce the need for some chemical interventions.
Non-chemical methods, such as mechanical and thermal sea lice removal, cleaner fish, UV and ozone treatment, partly replace chemical treatments.
Substitutes generally complement rather than fully replace water quality management and disinfection.
Intensity of Competitive Rivalry – High
The market is fragmented, with multinational suppliers competing against many regional formulators.
Product differentiation is limited in commodity disinfectants and conditioners, leading to price competition.
Competition in probiotics is increasing as feed, animal health and biosolutions companies expand their ranges.
Threat of New Entrants: Medium; Low barriers for generic products; high regulatory barriers for registered medicines and biocides.
Bargaining Power of Suppliers: Medium; Concentrated supply of key oxidisers; commodity nature of many inputs.
Bargaining Power of Buyers: High; Price-sensitive farmers and volume purchasing by integrators.
Threat of Substitutes: Medium; Vaccines, genetics and non-chemical treatments reduce some chemical use.
Intensity of Competitive Rivalry: High; Fragmented market and price competition in generic categories.
Market estimates by geography (2032)
InsightAsia Pacific leads with $236.43M by 2032, while Middle East & Africa is projected to grow fastest at a 6.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $9.57M | $11.64M | $14.15M | 4.0% | 5% |
| Europe | $13.48M | $16.23M | $19.53M | 3.8% | 7% |
| Asia Pacific | $150.24M | $188.56M | $236.43M | 4.6% | 80% |
| Latin America | $11.08M | $14.30M | $18.46M | 5.2% | 6% |
| Middle East & Africa | $3.60M | $4.85M | $6.55M | 6.2% | 2% |
| Total | $187.96M | $235.58M | $295.12M | 4.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$295.12M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Probiotics & Others | $127.07M | 5.8% | 43% |
| Water Quality Conditioners | $86.69M | 4.3% | 29% |
| Disinfectants | $81.36M | 3.4% | 28% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Aquaculture Chemicals Market covering market dynamics, competitive landscape, and strategic outlook.
The Aquaculture Chemicals Market market is projected to reach $295.12M by 2032, growing at 4.6% CAGR. The Probiotics & Others segment holds the largest share.
The Global Aquaculture Chemicals Market is shaped by the growth and intensification of aquaculture production, the economic impact of disease, and regulatory measures that restrict antibiotic use and govern the approval of fish medicines and biocides. This chapter assesses the macro and micro factors influencing the market, followed by the principal drivers, restraints, opportunities, trends and challenges. The impact scores presented in Section 4.2 are analyst assessments based on secondary and primary research; each factor is rated on a scale of 1 (minimal impact) to 10 (very high impact) for the periods 2026–2027, 2028–2030 and 2031–2032.
Expansion and Intensification of Global Aquaculture
Aquaculture is now the main source of aquatic animal supply. FAO's State of World Fisheries and Aquaculture 2024 reported that aquaculture produced 94.4 million tonnes of aquatic animals in 2022, compared with 92.3 million tonnes from capture fisheries, giving aquaculture a 51% share for the first time. Asia accounted for 70% of aquatic animal production, with China, India, Indonesia and Viet Nam the leading producers. Because wild catch is largely capped, most of the future increase in seafood supply is expected to come from farming. Growth is being achieved not only through new farm area but also through higher stocking densities, multiple crop cycles per year and the adoption of intensive systems such as lined ponds, biofloc and RAS. Intensive systems accumulate organic matter, ammonia, nitrite and hydrogen sulphide more quickly and require regular pH and alkalinity correction, oxygen support and pond-bottom management. As a result, consumption of water quality conditioners, disinfectants and microbial products per hectare and per tonne of output rises as farms intensify, linking market growth directly to the structural development of the aquaculture sector.
Rising Disease Burden and Biosecurity Requirements
Disease is the largest source of economic loss in aquaculture. Research published in Asian Fisheries Science (Griffiths et al., 2018) estimated that acute hepatopancreatic necrosis disease (AHPND) caused production losses of USD 7.38 billion in Thailand between 2010 and 2017, along with USD 4.2 billion in export losses. In the Mekong Delta of Viet Nam, losses in 2015 exceeded USD 26 million from AHPND and USD 11 million from white spot syndrome virus (WSSV). In salmon farming, sea lice and gill diseases require repeated treatments: Sernapesca data for 2024 show that Chilean salmon farms used 12,112 tonnes of hydrogen peroxide during the year. These losses have made biosecurity a routine operating requirement rather than an emergency response. Hatcheries disinfect water, tanks and equipment between cycles, grow-out farms prepare ponds with disinfectants and liming agents before stocking, and farms increasingly apply probiotics to suppress pathogenic Vibrio populations. Certification schemes and buyer audits also require documented biosecurity protocols, which further supports regular product use.
Restrictions on Antibiotic Use
Regulators and seafood importers are tightening controls on antibiotic use and residues, which shifts demand towards disinfectants, water treatment and probiotics. In the European Union, Regulation (EU) 2019/6 on veterinary medicinal products has applied since 28 January 2022 and strengthens measures against antimicrobial resistance, including restrictions on preventive use and the reservation of certain antimicrobials for human medicine. In China, a 2019 guideline issued by ten central government agencies, including the Ministry of Agriculture and Rural Affairs, called for reduced drug use in aquaculture through vaccination and ecological disease prevention, and for stronger control of drug-use records and counterfeit products. India's Coastal Aquaculture Authority maintains a list of antibiotics and pharmacologically active substances banned in coastal aquaculture, and residue testing is a condition for access to export markets. Because antibiotics are no longer a dependable tool for routine disease control, farms rely more on preventive measures, such as pond disinfection, water quality management and beneficial bacteria, to keep pathogen loads low.
Government Investment and Export-Oriented Shrimp Farming
Public investment and export demand are expanding the farmed area and the number of commercial producers using purchased inputs. India's Pradhan Mantri Matsya Sampada Yojana (PMMSY) has a total investment of INR 20,050 crore for FY2020-21 to FY2024-25 and has been extended to FY2025-26; India's fish production rose from 96 lakh tonnes in 2013-14 to 195 lakh tonnes in 2024-25. Shrimp exports underpin this growth: according to MPEDA, India exported seafood worth USD 7.45 billion in FY2024-25, with frozen shrimp accounting for 69.46% of export earnings. In Latin America, Ecuador exported 2.67 billion pounds (about 1.21 million tonnes) of shrimp worth USD 6.07 billion in 2024, according to the National Aquaculture Chamber. Export-oriented farms operate under residue testing and buyer audits, and they invest in hatchery biosecurity, pond preparation and water quality products to protect crop survival. Government programmes that fund hatcheries, disease diagnostic laboratories and farmer training also raise awareness of correct product use.
Next-Generation Probiotics and Bioremediation Products
Demand is growing for microbial products with documented strains and clear modes of action, such as pathogen exclusion, nitrogen removal and hydrogen sulphide reduction. Suppliers with fermentation capability and strain libraries, such as biosolutions and animal nutrition companies, can differentiate through product consistency, shelf stability and field trial data. Combining probiotics with diagnostic and water-testing services offers further scope for value-added offerings.
Water Treatment for RAS and Land-Based Farming
Investment in RAS and land-based salmon, shrimp and other species is creating demand for products suited to closed systems, where water is reused and biofilter stability must be protected. These systems require disinfectants that are compatible with biofilters, alkalinity and pH control, and controlled microbial management. Policy measures, such as Canada's planned transition away from open-net pen salmon farming in British Columbia coastal waters by 2029, may further support closed-containment production.
Emerging Aquaculture Markets
Aquaculture is expanding in the Middle East, Africa and parts of Latin America, supported by food security programmes and private investment. The Middle East & Africa market is forecast to grow at a CAGR of 6.18% during 2026–2032, the highest of any region, with Saudi Arabia at 8.30%. Brazil is forecast to grow at a CAGR of 6.50%. New farms in these markets are often built to modern biosecurity standards from the outset, creating opportunities for suppliers that establish distribution and technical support early.
Cost and Complexity of Regulatory Approval
Fish medicines and biocidal products require registration before they can be sold, and aquaculture is a small market relative to the cost of generating efficacy, target-animal safety, residue and environmental data. In the United States, only a limited number of drugs are approved for aquaculture use by the FDA. In the European Union, biocidal products require approval of the active substance and authorisation of the product under Regulation (EU) No 528/2012. These requirements limit the number of products available for minor species and slow the introduction of new active ingredients, which constrains market expansion in regulated regions.
Environmental and Residue Concerns
Chemicals discharged from farms can affect non-target organisms and receiving waters. Formalin, chlorine compounds and some anti-parasitic bath treatments face scrutiny from environmental regulators, local communities and retailers. Discharge limits, withdrawal periods and residue monitoring increase the cost of compliance and encourage farms to reduce chemical use where alternatives exist, which restrains volume growth for conventional disinfectants and treatments.
Price Sensitivity and Unregistered Products
A large share of global aquaculture output comes from small and medium farms in Asia, Africa and Latin America that operate on narrow margins. These farmers are sensitive to input prices and often buy low-cost generic products through local dealers. The availability of unregistered or poorly labelled products in some markets creates price competition for registered brands and can lead to inconsistent results, which reduces farmer confidence in product categories such as probiotics.
Shift from Treatment to Prevention
Farm health management is moving from reactive treatment of outbreaks towards preventive programmes built around pond preparation, routine water conditioning, probiotics and strict hatchery biosecurity. This trend favours products used on a regular schedule over those used only during disease events, and supports the faster growth of the Probiotics & Others and Water Quality Conditioners segments.
Consolidation and Portfolio Restructuring
Major suppliers have reshaped their aquaculture portfolios since 2022. Merck Animal Health completed its USD 1.3 billion acquisition of Elanco's aqua business in July 2024; Novozymes and Chr. Hansen combined to form Novonesis in January 2024; Benchmark Holdings sold its genetics business in March 2025 to focus on nutrition and health; and dsm-firmenich agreed in February 2026 to divest its Animal Nutrition & Health business. These moves concentrate aquaculture health capabilities in fewer, larger portfolios.
Digital Monitoring and Precision Dosing
Low-cost sensors for dissolved oxygen, pH, temperature and ammonia, together with farm management software, allow farmers to apply conditioners and probiotics based on measured needs rather than fixed schedules. Precision dosing can improve outcomes and reduce waste, and suppliers are increasingly linking product recommendations to water-testing and advisory services.
Challenge: Treatment Resistance and Efficacy
Repeated use of the same treatments can reduce their effectiveness. Reduced sensitivity of sea lice to several chemical treatments has been reported in salmon-producing countries, and inconsistent quality in some probiotic products has limited farmer confidence. Maintaining efficacy requires rotation of treatment types, integrated pest management and investment in product quality and field validation.
The aquaculture chemicals value chain extends from commodity and biological raw materials to farm-level application. Value is added mainly at the formulation, registration and technical service stages.
Aquaculture chemicals are regulated under different frameworks depending on their intended use: products that treat or prevent disease in animals are generally regulated as veterinary medicines, products that disinfect surfaces and water are regulated as biocides or pesticides, and products added to feed are regulated as feed additives. The principal frameworks in major regions are summarised below.
Mar 2022: Syndel; Approval; Syncaine (MS-222) anaesthetic received a marketing authorisation in the United Kingdom.
Jul 2022: LANXESS; Acquisition; Completed the acquisition of IFF's Microbial Control business, adding disinfectant and preservative capabilities to its Consumer Protection segment.
Aug 2022: Syndel; Launch; Made HALAMID AQUA (chloramine-T) available to aquaculture customers.
Oct 2022: LANXESS / Syndel; Approval; Virkon Aquatic disinfectant approved for use in California.
Apr 2023: Kemin AquaScience; Launch; Launched PATHOROL for shrimp health in India, Thailand, Viet Nam, Indonesia and Singapore.
Jan 2024: Novonesis; Merger; Completed the combination of Novozymes and Chr. Hansen, creating Novonesis.
Jul 2024: Merck Animal Health; Acquisition; Completed the USD 1.3 billion acquisition of Elanco's aqua business, including water-treatment products and manufacturing sites in Canada and Viet Nam.
Aug 2024: Lallemand Animal Nutrition; Partnership; Launched the LALProMucoBath research project with the University of Plymouth on restoring salmon skin and gill microbiomes after bath treatments.
Mar 2025: Benchmark Holdings; Divestment; Completed the sale of its Genetics business to Novo Holdings to focus on its Advanced Nutrition (INVE Aquaculture) and Health divisions.
Jun 2025: Novonesis; Acquisition; Completed the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion.
Feb 2026: dsm-firmenich; Divestment; Agreed to divest its Animal Nutrition & Health business, which includes the AquaStar range, to CVC Capital Partners.
Mar 2026: Syndel; Approval; Syncaine vet. authorised in Norway by the Norwegian Medical Products Agency, following its authorisation in Chile.
Political
Governments in India, China, the Gulf states and Brazil are supporting aquaculture expansion through investment schemes and food security strategies.
Trade policy changes and import tariffs on seafood can affect the profitability of export-oriented farms and their spending on inputs.
Economic
Farm-gate prices for shrimp and salmon influence farmers' willingness to spend on preventive products.
Raw material and energy prices affect production costs for oxidisers, halogen compounds and fermented products.
Disease-related losses provide a strong economic case for biosecurity spending.
Social
Rising seafood consumption in Asia and other regions increases demand for farmed fish and shrimp.
Consumer and retailer concerns about antibiotic residues and food safety encourage the use of preventive and biological products.
Technological
Advances in strain selection and fermentation are improving the consistency of probiotic products.
RAS, biofloc and sensor-based water monitoring change the type and frequency of chemical use.
Closed treatment and dosing systems allow more controlled application of bath treatments.
Environmental
Rising water temperatures and extreme weather events increase disease pressure and water quality stress.
Restrictions on farm effluents and chemical discharges favour biodegradable and low-residue products.
Legal
Registration requirements for veterinary medicines, biocides and feed additives determine which products can be sold in each country.
Maximum residue limits and import testing by major seafood importers influence product choice by exporting farms.
Profiles of 30 companies operating in the Aquaculture Chemicals Market market, including revenue, employee count, and market positioning where available.
Showing 30 of 30 companies
| Metric | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---| | Employees (approx., headcount) | 9000 | 9000 | 8700 | 8400 | Note: FY2023–FY2025 are approximations from company communications; the FY2025 figure is an interpolation and should be treated as not publicly verified. FY2026 (~8,400) is stated in every 2026 Solvay press release. The FY2025 media presentation references a workforce trajectory toward ~9,000 "by 2027" in a context that could not be fully parsed. Solvay is a 163-year-old Belgian producer of essential, largely commoditised inorganic and mid-chain chemicals whose franchise rests on scale, cost position and process know-how rather than proprietary molecules. Post-demerger, the group is anchored by two global leaderships — soda ash and its derivatives (including sodium bicarbonate) and hydrogen peroxide — complemented by highly dispersible silica for fuel-efficient tyres, the Brazil-based Coatis phenol/solvents chain, and a Special Chem unit housing rare earths and fluorine. With €4.3 billion of underlying sales and an EBITDA margin that has stayed above 20% through a severe soda ash downcycle, Solvay positions itself as a cash-generating, dividend-paying "essential chemistry" company. Its equity story now pivots on three levers: structural cost reduction (€300 million cumulative by end-2026), decarbonisation of coal-fired soda ash plants, and optionality in Western rare earths separation at La Rochelle — an asset increasingly seen as strategic outside China. --- ### Company's own description Solvay describes itself as "a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process," delivering essential solutions that address needs such as purifying air and water, preserving food, protecting health, making tyres more sustainable, and cleaning and protecting homes. Its corporate purpose, as presented with FY2025 results, is "essential chemistry, making progress possible for generations," executed through four strategic levers: operational excellence, energy transition, process innovation and production capacity (Source: FY2025 media presentation, 24 Feb 2026). ### Independent characterisation Solvay is today a mid-cap, cyclical, largely B2B commodity and intermediate chemicals producer. Roughly 60% of sales and around two-thirds of segment EBITDA come from Basic Chemicals (soda ash, bicarbonate, peroxides), where pricing is set by global supply-demand balances — notably the seaborne soda ash market, which has been depressed by Chinese and Turkish capacity additions. The remaining ~40% of sales (Performance Chemicals) are more differentiated (silica for tyres, rare earths formulations, autocatalyst materials, fluorine specialties, phenol/solvent chain) but smaller and more volatile in margin. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue mix | ~100% product sales; no material service, subscription or licensing revenue disclosed. Minor technology/licensing elements exist (e.g., samarium process technology supplied to Permag, 2025) but are not separately reported | | Contract structure | Soda ash: largely annual contracts in Europe/US, spot/short-term in seaborne Asia; peroxides: long-term on-site/captive supply to HPPO (propylene oxide) plants plus merchant sales; silica: multi-year qualifications with tyre makers | | Value chain position | Upstream/mid-stream: converts salt, limestone, trona, hydrogen, natural gas/energy and mineral concentrates into base inorganic chemicals and intermediates | | Cost drivers | Energy (gas, coal, power), CO2 allowances (EU ETS), freight, raw materials (limestone, salt, trona, ore concentrates), fixed costs | | Customer types | Glass manufacturers (flat, container, solar), detergent producers, chemical companies, tyre makers, pulp & paper, electronics/semiconductor fabs, food/feed/pharma, flue gas treatment operators, mining, automotive catalysts, magnet makers | | End-markets | Construction and automotive glass, solar glass, consumer goods (detergents), food & pharma (bicarbonate), environment (flue gas treatment, water), semiconductors (electronic-grade H2O2), mobility (tyres, catalysts, EV magnets), agro and coatings (solvents) | ### Segment business descriptions (as defined by Solvay) **Basic Chemicals:** Soda Ash & Derivatives and Peroxides businesses. **Performance Chemicals:** Coatis, Silica and Special Chem businesses (Source: Q1/Q2/FY2025 media presentations). **Corporate & Business Services:** corporate functions, energy services and other.
3 interactive charts drawn from the Aquaculture Chemicals Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Aquaculture Chemicals Market By Species
Global Aquaculture Chemicals Market By Product Type
Global Aquaculture Chemicals Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
